Madison Healthcare Services | |
900 Second Avenue, Madison, Minnesota 56256 | |
(320) 598-7536 | |
Name | Madison Healthcare Services |
---|---|
Location | 900 Second Avenue, Madison, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 56 |
Occupancy Rate | 70% |
Medicare ID (CCN) | 245382 |
Legal Business Name | Madison Healthcare Services |
Ownership Type | Non Profit - Church Related |
NPI Number | 1306832795 |
Organization Name | MADISON HEALTHCARE SERVICES |
Doing Business As | MADISON LUTHERAN HOME |
Address | 900 2nd Ave, Madison, MN 56256 |
Phone Number | 320-598-7536 |
News Archive
In a letter to the Editor published this Wednesday (31st May 2017), a group of Canadian researchers have disclosed how a sting of words coming from a notable doctor nearly 4 decades ago was the seed that led to a nationwide epidemic of misuse and abuse of opioid painkiller drugs such as Vicodin and OxyContin.
EpiCept Corporation announced today that it has entered into an exclusive commercialization agreement for Ceplene® (histamine dihydrochloride) with Meda AB, a leading international specialty pharmaceutical company based in Stockholm. Ceplene is EpiCept's novel therapy approved in the European Union with orphan drug status for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
Nanomaterials are the heart of the smaller, better electronics developed during the last decade, as well as new materials, medical diagnostics and therapeutics, energy storage, and clean water. However, exposure to nanomaterials may have unintended consequences for human health and the environment.
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
Researchers have developed a photoacoustic imaging technique that uses lasers to create detailed ultrasound images in live animals. The method allows for complete internal body scans with enough spatiotemporal resolution to see active organs, circulating cancer cells, and brain function.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
In a letter to the Editor published this Wednesday (31st May 2017), a group of Canadian researchers have disclosed how a sting of words coming from a notable doctor nearly 4 decades ago was the seed that led to a nationwide epidemic of misuse and abuse of opioid painkiller drugs such as Vicodin and OxyContin.
EpiCept Corporation announced today that it has entered into an exclusive commercialization agreement for Ceplene® (histamine dihydrochloride) with Meda AB, a leading international specialty pharmaceutical company based in Stockholm. Ceplene is EpiCept's novel therapy approved in the European Union with orphan drug status for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
Nanomaterials are the heart of the smaller, better electronics developed during the last decade, as well as new materials, medical diagnostics and therapeutics, energy storage, and clean water. However, exposure to nanomaterials may have unintended consequences for human health and the environment.
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
Researchers have developed a photoacoustic imaging technique that uses lasers to create detailed ultrasound images in live animals. The method allows for complete internal body scans with enough spatiotemporal resolution to see active organs, circulating cancer cells, and brain function.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 15.03 | 14.46 |
Percentage of long-stay residents who lose too much weight | 2.33 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 44.44 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.14 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.16 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 12.5 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 7.33 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.43 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 10.64 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 82.76 | 83.88 |